IndraLab

Statements


USP35 activates CD4. 1 / 1
| 1

reach
"To better understand how USP35 modulates the anti-tumor ability of oncolytic virotherapy, CD4 /CD8 T cell and macrophage type were analyzed by flow cytometric assays (Supplementary Fig. 5A, B, Supplementary Fig. 6A, B)."